Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInterest Coverage RatioInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on SalesTimes Interest Earned

Zevra Therapeutics (ZVRA) Return on Assets (2016 - 2025)

Zevra Therapeutics' Return on Assets history spans 10 years, with the latest figure at 0.3% for Q4 2025.

  • For Q4 2025, Return on Assets rose 87.0% year-over-year to 0.3%; the TTM value through Dec 2025 reached 0.3%, up 87.0%, while the annual FY2025 figure was 0.36%, 96.0% up from the prior year.
  • Return on Assets reached 0.3% in Q4 2025 per ZVRA's latest filing, up from 0.13% in the prior quarter.
  • In the past five years, Return on Assets ranged from a high of 76.06% in Q3 2022 to a low of 0.57% in Q4 2024.
  • Average Return on Assets over 5 years is 3.99%, with a median of 0.27% recorded in 2023.
  • The largest YoY upside for Return on Assets was 7613bps in 2022 against a maximum downside of -51bps in 2022.
  • A 5-year view of Return on Assets shows it stood at 0.06% in 2021, then crashed by -798bps to 0.57% in 2022, then soared by 58bps to 0.24% in 2023, then plummeted by -139bps to 0.57% in 2024, then surged by 153bps to 0.3% in 2025.
  • Per Business Quant, the three most recent readings for ZVRA's Return on Assets are 0.3% (Q4 2025), 0.13% (Q3 2025), and 0.01% (Q2 2025).